Prevention of insulin self-association and surface adsorption.

No abstract is available for this paper.

• Publication year

  1983

• Venue

  Journal of Pharmacy and Science

• Publication date

  1983-03-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1002/JPS.2600720307PMID 6341536
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prevention of Insulin Aggregation by Dicarboxylic Amino Acids During Prolonged Infusion

  1981cited by this paper
• Role of binders in moisture-induced hardness increase in compressed tablets and its effect on in vitro disintegration and dissolution.

  1980cited by this paper
• Nonaggregating Insulin Solutions for Long-Term Glucose Control in Experimental and Human Diabetes

  1980cited by this paper
• Insulin aggregation in artificial delivery systems

  1980cited by this paper
• Insulin permeability of hydrophilic polyacrylate membranes.

  1980cited by this paper
• Zinc binding, circular dichroism, and equilibrium sedimentation studies on insulin (bovine) and several of its derivatives.

  1974cited by this paper
• Ultraviolet rotatory properties of polypeptides in solution. II. Poly-L-serine.

  1968cited by this paper
• An equilibrium ultracentrifuge study of the self-association of bovine insulin.

  1966cited by this paper
• Reversible Dissociation of Insulin

  1953cited by this paper

• Insulin Stabilization Designs for Enhanced Therapeutic Efficacy and Accessibility.

  2024cites this paper
• Clinical Recommendations for Managing the Impact of Insulin Adsorptive Loss in Hospital and Diabetes Care

  2020cites this paper
• Capacity of Infusion Lines for Insulin Adsorption: Effect of Flow Rate on Total Adsorption

  2019cites this paper
• Modelling insulin adsorption in intravenous infusion sets in the intensive care unit

  2019cites this paper
• Pure insulin highly respirable powders for inhalation.

  2014cites this paper
• Conductive polymer nanotube patch for fast and controlled ex vivo transdermal drug delivery.

  2014cites this paper
• Microchips and controlled-release drug reservoirs.

  2010cites this paper
• Role of a Novel Excipient Poly(Ethylene Glycol)-b-Poly(L-Histidine) in Retention of Physical Stability of Insulin in Aqueous Solutions

  2007cites this paper
• Application of Micro- and Nano-Electromechanical Devices to Drug Delivery

  2006cites this paper
• Principles of Biopharmaceutical Protein Formulation

  2005cites this paper
• Therapeutic Proteins

  2005influential citation
• Therapeutic peptides and proteins : formulation, processing, and delivery systems

  2005cites this paper
• State of insulin self-association does not affect its absorption from the pulmonary route.

  2005cites this paper
• Preformulation and Formulation of Therapeutic Peptides and Proteins

  2005cites this paper
• Evidence for restrictive parameters in formulation of insulin-loaded nanocapsules.

  2004cites this paper
• Insulin Nanoparticles: A Novel Formulation Approach for Poorly Water Soluble Zn-Insulin

  2004cites this paper
• Improved formulation of W/O/W multiple emulsion for insulin encapsulation. Influence of the chemical structure of insulin

  2004cites this paper
• Transdermal iontophoresis of insulin: IV. Influence of chemical enhancers.

  2004cites this paper
• Transdermal Iontophoresis of Insulin

  2004cites this paper
• Feeding liquid, non-ionic surfactant and cyclodextrin affect the properties of insulin-loaded poly(lactide-co-glycolide) microspheres prepared by spray-drying.

  2003cites this paper
• Transdermal iontophoresis of insulin. V. Effect of terpenes.

  2003cites this paper
• A reversible hydrogel membrane for controlling the delivery of macromolecules.

  2003cites this paper
• Transdermal iontophoresis of insulin. Part 1: A study on the issues associated with the use of platinum electrodes on rat skin

  2003cites this paper
• Monitoring the in Vivo Delivery of Proteins from Carbomer Hydrogels by X-Ray Fluorescence

  2003cites this paper
• Transdermal iontophoresis of insulin. II. Physicochemical considerations.

  2003cites this paper
• Formulation development of protein dosage forms.

  2002cites this paper
• Development and Manufacture of Protein Pharmaceuticals

  2002cites this paper
• Effects of Low-Viscosity Sodium Hyaluronate Preparation on the Pulmonary Absorption of rh-Insulin in Rats

  2001cites this paper
• Modulated insulin delivery from glucose-sensitive hydrogel dosage forms.

  2001cites this paper
• Transdermal iontophoretic delivery of bovine insulin and monomeric human insulin analogue.

  1999cites this paper
• Peptides and Proteins as Parenteral Solutions

  1999cites this paper
• PROTEIN ADSORPTION IN RELATION TO SOLUTION ASSOCIATION AND AGGREGATION

  1998cites this paper
• Analysis of Peptides and Proteins: Evaluation of Purity, Stability, and Structural Characterization of Insulin

  1997cites this paper
• Varying effects of cyclodextrin derivatives on aggregation and thermal behavior of insulin in aqueous solution.

  1997cites this paper
• Use of poloxamer polymers to stabilize recombinant human growth hormone against various processing stresses.

  1997cites this paper
• Characterization of protein release through glucose-sensitive hydrogel membranes.

  1997cites this paper
• Insulin formulation and delivery.

  1997cites this paper
• Stabilization of insulin by alkylmaltosides. B. Oral absorption in vivo in rats

  1996cites this paper
• Stabilization of insulin by alkylmaltosides. A. Spectroscopic evaluation

  1996cites this paper
• Immunological and formulation design considerations for subunit vaccines.

  1995cites this paper
• Quality evaluation of commercial lyophilized human growth hormone preparations.

  1995cites this paper
• Physical stabilization of insulin by glycosylation.

  1995cites this paper
• Self-Regulated Insulin Delivery-Artificial Pancreas

  1994cites this paper
• Kinetics and mechanisms of peptide aggregation. I: Aggregation of a cholecystokinin analogue.

  1993cites this paper
• Chemical and α-Chymotrypsin-Mediated Proteolytic Degradation of Insulin in Bile Salt-Unsaturated Fatty Acid Mixed Micellar Systems

  1993cites this paper
• Differential Effects of Anionic, Cationic, Nonionic, and Physiologic Surfactants on the Dissociation, α-Chymotryptic Degradation, and Enteral Absorption of Insulin Hexamers

  1993cites this paper
• Loss of LDH activity during membrane filtration.

  1993cites this paper
• Biological Barriers to Protein Delivery

  1993cites this paper
• Minimization of shaking-induced formation of insoluble aggregates of insulin by cyclodextrins.

  1993cites this paper
• Analysis of proinsulin and its conversion products by reversed-phase high-performance liquid chromatography.

  1993cites this paper
• Dermal Absorption of Peptides and Proteins

  1993cites this paper
• Characterization of in Vitro Transdermal Iontophoretic Delivery of Insulin

  1993cites this paper
• Drug Delivery Aspects of Biotechnology Products

  1993cites this paper
• The Immune System as a Barrier to Delivery of Protein Therapeutics

  1993cites this paper
• Hyaluronane derivative microspheres as NGF delivery devices: Preparation methods and in vitro release characterization

  1992cites this paper
• Formulation concerns of protein drugs

  1992cites this paper
• Cyclodextrins as Nasal Absorption Promoters of Insulin: Mechanistic Evaluations

  1992cites this paper
• Dissociation of Insulin Oligomers by Bile Salt Micelles and Its Effect on α-Chymotrypsin-Mediated Proteolytic Degradation

  1992cites this paper
• Insulin stabilization and GI absorption

  1992cites this paper
• Insulin Aggregation in Aqueous Media and Its Effect on Alpha-Chymotrypsin-Mediated Proteolytic Degradation

  1991cites this paper
• Insulin adsorption to parenteral infusion systems: case report and review of the literature.

  1990cites this paper
• Application of scanning electron microscopy and energy-dispersive X-ray analysis to the solution behaviour of Zn-insulin: precipitation phenomena.

  1989cites this paper
• Effect of sodium glycocholate and polyoxyethylene-9-lauryl ether on the hydrolysis of varying concentrations of insulin in the nasal homogenates of the albino rabbit.

  1989cites this paper
• Potential Developments in Systemic Delivery of Insulin

  1989cites this paper
• Effect of dose, pH, and osmolarity on nasal absorption of secretin in rats. III. In vitro membrane permeation test and determination of apparent partition coefficient of secretion.

  1989cites this paper
• Stability of Protein Pharmaceuticals

  1989cites this paper
• Self-association and solubility behaviors of a novel anticancer agent, brequinar sodium.

  1989cites this paper
• Diffusion électrolytique transdermique de protéines

  1988cites this paper
• Systemic delivery of therapeutic peptides and proteins

  1988cites this paper
• Facilitated transdermal transport of insulin.

  1987cites this paper
• Binding of human insulin to burette administration sets

  1987cites this paper
• The source of the circulating aggregate of insulin in type I diabetic patients is therapeutic insulin.

  1986cites this paper
• Neutral Insulin Solutions Physically Stabilized by Addition of Zn2+

  1986cites this paper
• Prevention of molecular self-association by sodium salicylate: effect on methylene blue.

  1986cites this paper
• Chemical stability of insulin in a delivery system environment

  1985cites this paper
• Pump-induced Insulin Aggregation: A Problem with the Biostator

  1985cites this paper
• Self-reguiating isnssultn delivery systems II. In vitro studies

  1984cites this paper
• Stabilisation of dissolved proteins against denaturation at hydrophobie interfaces

  1984influential citation
• Binding affinity of monoiodinated insulin tracers isolated after reversed-phase high-performance liquid chromatography.

  1983cites this paper
• Minimizing the aggregation of neutral insulin solutions.

  1983cites this paper
• Immobilization of urokinase on agarose matrices.

  1983cites this paper